Ten-eleven translocation-2 regulates DNA hydroxymethylation status and psoriasiform dermatitis progression in mice

Acta Dermato-Venereologica

Volumn 98, Issue 6, 2018, Pages 585-593

  Wang, Xin ^a,b   Liu, Xinxin ^a   Duan, Xiaoru ^a   Zhu, Ke ^a   Zhang, Song ^a   Gan, Lu ^a   Liu, Nian ^a   Jaypaul, Himanshu ^a   Makamure, Johanna T ^a   Ming, Zhangyin ^a   Chen, Hongxiang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

5 hydroxymethylcytosine; Epigenetics; Psoriasis; Ten eleven translocation 2; Th17 cell

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; DIOXYGENASE; GAMMA INTERFERON; GENOMIC DNA; IMIQUIMOD; INTERLEUKIN 17; INTERLEUKIN 17F; SHORT HAIRPIN RNA; TEN ELEVEN TRANSLOCATION 2; UNCLASSIFIED DRUG; 5 METHYLCYTOSINE; 5-HYDROXYMETHYLCYTOSINE; AMINOQUINOLINE DERIVATIVE; CXCL1 CHEMOKINE; CXCL1 PROTEIN, MOUSE; DNA BINDING PROTEIN; IFNG PROTEIN, MOUSE; IL17A PROTEIN, MOUSE; IL17F PROTEIN, MOUSE; ONCOPROTEIN; TET2 PROTEIN, HUMAN; TET2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE KNOCKDOWN; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; TH17 CELL; ANALOGS AND DERIVATIVES; ANIMAL; BAGG ALBINO MOUSE; CASE CONTROL STUDY; CELL DIFFERENTIATION; CHEMICALLY INDUCED; DISEASE EXACERBATION; DISEASE MODEL; GENETIC EPIGENESIS; GENETICS; HUMAN; METABOLISM; PATHOLOGY; SKIN; TIME FACTOR;

5-METHYLCYTOSINE; AMINOQUINOLINES; ANIMALS; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMOKINE CXCL1; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DNA METHYLATION; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; MICE, INBRED BALB C; PROTO-ONCOGENE PROTEINS; PSORIASIS; SKIN; TIME FACTORS;

EID: 85048512988     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-2926     Document Type: Article

References (31)

1. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med 2009; 361: 496–509.
2. Zaba LC, Fuentes-Duculan J, Eungdamrong NJ, Abello MV, Novitskaya I, Pierson KC, et al. Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol 2009; 129: 79–88.
3. Boehncke WH. Psoriasis and psoriatic arthritis: flip sides of the coin? Acta Derm Venereol 2016; 96: 436–441.
4. Zhou F, Wang W, Shen C, Li H, Zuo X, Zheng X, et al. Epigenome-wide association analysis identified nine skin DNA methylation loci for psoriasis. J Invest Dermatol 2016; 136: 779–787.
5. Roberson ED, Liu Y, Ryan C, Joyce CE, Duan S, Cao L, et al. A subset of methylated CpG sites differentiate psoriatic from normal skin. J Invest Dermatol 2012; 132: 583–592.
6. Lei W, Luo Y, Lei W, Luo Y, Yan K, Zhao S, et al. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyo-sitis. Scand J Rheumatol 2009; 38: 369–374.
7. Lu Q. The critical importance of epigenetics in autoimmunity. J Autoimmun 2013; 41: 1–5.
8. Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, et al. Tet proteins can convert 5-methylcytosine to 5-formylcyto-sine and 5-carboxylcytosine. Science 2011; 333: 1300–1303.
9. Pastor WA, Aravind L, Rao A. TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nat Rev Mol Cell Biol 2013; 14: 341–356.
10. He YF, Li BZ, Li Z, Liu P, Wang Y, Tang Q, et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 2011; 333: 1303–1307.
11. Barazeghi E, Gill AJ, Sidhu S, Norlen O, Dina R, Palazzo FF, et al. A role for TET2 in parathyroid carcinoma. Endocr Relat Cancer 2017; 24: 329–338.
12. Ichiyama K, Chen T, Wang X, Yan X, Kim BS, Tanaka S, et al. The methylcytosine dioxygenase Tet2 promotes DNA demethylation and activation of cytokine gene expression in T cells. Immunity 2015; 42: 613–626.
13. Solary E, Bernard OA, Tefferi A, Fuks F, Vainchenker W. The ten-eleven translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases. Leukemia 2014; 28: 485–496.
14. Zang S, Li J, Yang H, Zeng H, Han W, Zhang J, et al. Mutations in 5-methylcytosine oxidase TET2 and RhoA cooperatively disrupt T cell homeostasis. J Clin Invest 2017; 127: 2998–3012.
15. Chen Q, Chen Y, Bian C, Fujiki R, Yu X. TET2 promotes histone O-GlcNAcylation during gene transcription. Nature 2013; 493: 561–564.
16. Zhang Q, Zhao K, Shen Q, Han Y, Gu Y, Li X, et al. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature 2015; 525: 389–393.
17. Han J, Park SG, Bae JB, Choi J, Lyu JM, Park SH, et al. The characteristics of genome-wide DNA methylation in naive CD4+ T cells of patients with psoriasis or atopic dermatitis. Biochem Biophys Res Commun 2012; 422: 157–163.
18. van der Fits L, Mourits S, Voerman JSA, Kant M, Boon L, Laman JD, et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 Axis. J Immunol 2009; 182: 5836.
19. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 2010; 8: e1000412.
20. Colombo M, Raposo G, Thery C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 2014; 30: 255–289.
21. Zhang P, Su Y, Chen H, Zhao M, Lu Q. Abnormal DNA methylation in skin lesions and PBMCs of patients with psoriasis vulgaris. J Dermatol Sci 2010; 60: 40–42.
22. Greco CM, Kunderfranco P, Rubino M, Larcher V, Carullo P, Anselmo A, et al. DNA hydroxymethylation controls cardio-myocyte gene expression in development and hypertrophy. Nat Commun 2016; 7: 12418.
23. Bhattacharyya S, Pradhan K, Campbell N, Mazdo J, Vasant-kumar A, Maqbool S, et al. Altered hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways. Genome Res 2017; 27: 1830–1842.
24. Ponciano-Gomez A, Martinez-Tovar A, Vela-Ojeda J, Olarte-Carrillo I, Centeno-Cruz F, Garrido E. Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia. Tumour Biol 2017; 39: 1010428317732181.
25. Seritrakul P, Gross JM. Tet-mediated DNA hydroxymethylation regulates retinal neurogenesis by modulating cell-extrinsic signaling pathways. PLoS Genet 2017; 13: e1006987.
26. Ansel KM, Lee DU, Rao A. An epigenetic view of helper T cell differentiation. Nat Immunol 2003; 4: 616–623.
27. Kurschus FC, Moos S. IL-17 for therapy. J Dermatol Sci 2017; 87: 221–227.
28. Kubin ME, Kokkonen N, Palatsi R, Hagg PM, Vayrynen JP, Glumoff V, et al. Clinical efficiency of topical calcipotriol/ betamethasone treatment in psoriasis relies on suppression of the inflammatory TNFalpha-IL-23-IL-17 Axis. Acta Derm Venereol 2017; 97: 449–455.
29. Liu X, Wang X, Duan X, Poorun D, Xu J, Zhang S, et al. Lipoxin A4 and its analog suppress inflammation by modulating HMGB1 translocation and expression in psoriasis. Sci Rep 2017; 7: 7100.
30. Xu N, Meisgen F, Butler LM, Han G, Wang XJ, Soderberg-Naucler C, et al. MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40. J Immunol 2013; 190: 678–688.
31. Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol 2010; 28: 1057–1068.